Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00239174 | A Multicenter Study to Evaluate the Efficacy and Safety of of Four Doses of SR147778 in Obese Patients | PHASE2 | COMPLETED | 394 | — | — | Nov 1, 2004 | Nov 1, 2005 | Dec 10, 2008 | 5 | Argentina, Australia +3 |
| Name | Type | Description |
|---|---|---|
| SR147778 | DRUG | - |
Inclusion Criteria: * Patients must voluntarily sign the informed consent, * Patients must be male or female and aged 18 to 65 years, * Patients must be able to follow verbal and written instructions, * Female patients of childbearing potential (pre-menopausal women) must have a confirmed negative ...